{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:47:13Z","timestamp":1792093633386,"version":"4.4.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jconrel.2025.114263","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T01:50:51Z","timestamp":1758765051000},"page":"114263","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"P1","title":["Development of a dissolving microneedle patch for transdermal delivery of SARS-CoV-2 mRNA vaccine with enhanced stability and immunogenicity"],"prefix":"10.1016","volume":"388","author":[{"given":"Zequn","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinzhong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.114263_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032700","article-title":"A comprehensive review of mRNA vaccines","volume":"24","author":"Gote","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2025.114263_bb0010","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jconrel.2021.03.043","article-title":"The dawn of mRNA vaccines: the COVID-19 case","volume":"333","author":"Verbeke","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114263_bb0015","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41586-020-2179-y","article-title":"Structural basis of receptor recognition by SARS-CoV-2","volume":"581","author":"Shang","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.114263_bb0020","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ymthe.2019.01.020","article-title":"mRNA as a transformative Technology for Vaccine Development to control infectious diseases","volume":"27","author":"Maruggi","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2025.114263_bb0025","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41541-020-0159-8","article-title":"The promise of mRNA vaccines: a biotech and industrial perspective","volume":"5","author":"Jackson","year":"2020","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.jconrel.2025.114263_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120586","article-title":"mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability","volume":"601","author":"Schoenmaker","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.114263_bb0035","doi-asserted-by":"crossref","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","article-title":"Lipid nanoparticlesfrom liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement","volume":"15","author":"Tenchov","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.114263_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114416","article-title":"The role of lipid components in lipid nanoparticles for vaccines and gene therapy","volume":"188","author":"Hald Albertsen","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.114263_bb0045","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.actbio.2021.06.023","article-title":"From influenza to COVID-19: lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases","volume":"131","author":"Pilkington","year":"2021","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2025.114263_bb0050","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2025.114263_bb0055","doi-asserted-by":"crossref","first-page":"319","DOI":"10.4155\/tde-2016-0006","article-title":"mRNA vaccine delivery using lipid nanoparticles","volume":"7","author":"Reichmuth","year":"2016","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.jconrel.2025.114263_bb0060","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2109256118","article-title":"On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles","volume":"118","author":"Dilliard","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2025.114263_bb0065","article-title":"Microneedle-mediated transcutaneous immunization: potential in nucleic acid vaccination","volume":"12","author":"Wang","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2025.114263_bb0070","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/14760584.2020.1732215","article-title":"The potential role of using vaccine patches to induce immunity: platform and pathways to innovation and commercialization","volume":"19","author":"Badizadegan","year":"2020","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.jconrel.2025.114263_bb0075","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jconrel.2022.05.045","article-title":"Dissolving microneedles: applications and growing therapeutic potential","volume":"348","author":"Sartawi","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114263_bb0080","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jconrel.2020.12.019","article-title":"Microneedles for painless transdermal immunotherapeutic applications","volume":"330","author":"Amani","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114263_bb0085","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1146\/annurev-immunol-051116-052215","article-title":"Antigen-presenting cells in the skin","volume":"35","author":"Kashem","year":"2017","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.114263_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113919","article-title":"Microneedle-mediated vaccination: innovation and translation","volume":"179","author":"Sheng","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.114263_bb0095","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.addr.2021.01.022","article-title":"Microarray patches enable the development of skin-targeted vaccines against COVID-19","volume":"171","author":"Korkmaz","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.114263_bb0100","article-title":"Dissolvable microneedle patches to enable increased access to vaccines against SARS-CoV-2 and future pandemic outbreaks","volume":"9","author":"O\u2019Shea","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.jconrel.2025.114263_bb0105","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.jconrel.2022.10.008","article-title":"Structural design strategies of microneedle-based vaccines for transdermal immunity augmentation","volume":"351","author":"Xu","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114263_bb0110","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.xphs.2020.12.006","article-title":"Addressing the cold reality of mRNA vaccine stability","volume":"110","author":"Crommelin","year":"2021","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2025.114263_bb0115","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/17425247.2023.2168641","article-title":"Accelerating the development of vaccine microarray patches for epidemic response and equitable immunization coverage requires investment in microarray patch manufacturing facilities","volume":"20","author":"Scarn\u00e0","year":"2023","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2025.114263_bb0120","first-page":"379","article-title":"Technology update: dissolvable microneedle patches for vaccine delivery","volume":"12","author":"Rodgers","year":"2019","journal-title":"Med. Dev. (Auckl)"},{"key":"10.1016\/j.jconrel.2025.114263_bb0125","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.actbio.2022.06.015","article-title":"Intradermal delivery of mRNA using cryomicroneedles","volume":"148","author":"Yu","year":"2022","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2025.114263_bb0130","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/s41587-023-01774-z","article-title":"A microneedle vaccine printer for thermostable COVID-19 mRNA vaccines","volume":"42","author":"Vander Straeten","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2025.114263_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125427","article-title":"Rapidly separable bubble microneedle-patch system present superior transdermal mRNA delivery efficiency","volume":"674","author":"Wu","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.114263_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102231","article-title":"Safety, immunogenicity, and efficacy of an mRNA COVID-19 vaccine (RQ3013) given as the fourth booster following three doses of inactivated vaccines: a double-blinded, randomised, controlled, phase 3b trial","volume":"64","author":"Liu","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jconrel.2025.114263_bb0145","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jconrel.2014.04.052","article-title":"Current advances in the fabrication of microneedles for transdermal delivery","volume":"185","author":"Indermun","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114263_bb0150","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s40005-021-00558-4","article-title":"Microneedle systems for delivering nucleic acid drugs","volume":"52","author":"Noh","year":"2022","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.jconrel.2025.114263_bb0155","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10202","article-title":"Intradermal delivery of receptor-binding domain of SARS-CoV-2 spike protein with dissolvable microneedles to induce humoral and cellular responses in mice","volume":"6","author":"Kuwentrai","year":"2021","journal-title":"Bioeng Transl. Med."},{"key":"10.1016\/j.jconrel.2025.114263_bb0160","doi-asserted-by":"crossref","first-page":"11842","DOI":"10.1038\/s41598-018-30290-3","article-title":"Formulation, characterization and evaluation of mRNA-loaded dissolvable polymeric microneedles (RNApatch)","volume":"8","author":"Koh","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2025.114263_bb0165","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jconrel.2005.02.002","article-title":"Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery","volume":"104","author":"Park","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114263_bb0170","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1097\/DSS.0000000000003108","article-title":"Comparing water absorption of Food and Drug Administration-approved hyaluronic acid fillers","volume":"47","author":"Woodward","year":"2021","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.jconrel.2025.114263_bb0175","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.actbio.2013.12.019","article-title":"Hyaluronan: a simple polysaccharide with diverse biological functions","volume":"10","author":"Dicker","year":"2014","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2025.114263_bb0180","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jconrel.2016.08.031","article-title":"Multilayered pyramidal dissolving microneedle patches with flexible pedestals for improving effective drug delivery","volume":"265","author":"Lau","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114263_bb0185","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jconrel.2017.10.021","article-title":"Dihydroergotamine mesylate-loaded dissolving microneedle patch made of polyvinylpyrrolidone for management of acute migraine therapy","volume":"268","author":"Tas","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114263_bb0190","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ejps.2014.09.011","article-title":"Investigation on fabrication process of dissolving microneedle arrays to improve effective needle drug distribution","volume":"66","author":"Wang","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2025.114263_bb0195","doi-asserted-by":"crossref","DOI":"10.3390\/ph15070897","article-title":"The future of tissue-targeted lipid nanoparticle-mediated nucleic acid delivery","volume":"15","author":"Kularatne","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.jconrel.2025.114263_bb0200","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.tips.2021.03.002","article-title":"The importance of apparent pKa in the development of nanoparticles encapsulating siRNA and mRNA","volume":"42","author":"Patel","year":"2021","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jconrel.2025.114263_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124799","article-title":"Effects of nanoparticle size, shape, and zeta potential on drug delivery","volume":"666","author":"\u00d6zt\u00fcrk","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.114263_bb0210","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1186\/s12951-024-02812-x","article-title":"Role of size, surface charge, and PEGylated lipids of lipid nanoparticles (LNPs) on intramuscular delivery of mRNA","volume":"22","author":"Kong","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2025.114263_bb0215","article-title":"Mechanism study on nanoparticle negative surface charge modification by Ascorbyl palmitate and its improvement of tumor targeting ability","volume":"27","author":"Li","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.jconrel.2025.114263_bb0220","doi-asserted-by":"crossref","DOI":"10.1080\/14686996.2024.2338785","article-title":"Fine tuning of the net charge alternation of polyzwitterion surfaced lipid nanoparticles to enhance cellular uptake and membrane fusion potential","volume":"25","author":"Homma","year":"2024","journal-title":"Sci. Technol. Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.114263_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124620","article-title":"Modelling insertion behaviour of PVP (Polyvinylpyrrolidone) and PVA (polyvinyl alcohol) microneedles","volume":"664","author":"Soorani","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.114263_bb0230","first-page":"3112","article-title":"Innovative freeze-drying technique in the fabrication of dissolving microneedle patch: enhancing transdermal drug delivery efficiency, drug Deliv","volume":"14","author":"Su","year":"2024","journal-title":"Transl. Res."},{"key":"10.1016\/j.jconrel.2025.114263_bb0235","doi-asserted-by":"crossref","first-page":"14347","DOI":"10.1021\/acsnano.1c03252","article-title":"Separable microneedle patch to protect and deliver DNA Nanovaccines against COVID-19","volume":"15","author":"Yin","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.114263_bb0240","doi-asserted-by":"crossref","first-page":"4995","DOI":"10.1039\/D3BM00182B","article-title":"Double-layered PLGA\/HA microneedle systems as a long-acting formulation of polyphenols for effective and long-term management of atopic dermatitis","volume":"11","author":"Chen","year":"2023","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2025.114263_bb0245","doi-asserted-by":"crossref","first-page":"eaaw8145","DOI":"10.1126\/sciadv.aaw8145","article-title":"Long-acting reversible contraception by effervescent microneedle patch","volume":"5","author":"Li","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2025.114263_bb0250","article-title":"Microneedles with controlled bubble sizes and drug distributions for efficient transdermal drug delivery","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2025.114263_bb0255","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jconrel.2015.11.019","article-title":"Microneedle patches for vaccination in developing countries","volume":"240","author":"Arya","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114263_bb0260","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.immuni.2021.06.017","article-title":"COVID-19 vaccine access in Africa: global distribution, vaccine platforms, and challenges ahead","volume":"54","author":"Massinga Loemb\u00e9","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2025.114263_bb0265","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14051066","article-title":"Potential of microneedle systems for COVID-19 vaccination: current trends and challenges","volume":"14","author":"Hassan","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.114263_bb0270","article-title":"Dendritic cell-mimicking nanoparticles promote mRNA delivery to lymphoid organs","volume":"10","author":"Cao","year":"2023","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.jconrel.2025.114263_bb0275","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.coviro.2021.03.008","article-title":"Future considerations for the mRNA-lipid nanoparticle vaccine platform","volume":"48","author":"Igy\u00e1rt\u00f3","year":"2021","journal-title":"Curr. Opin. Virol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925008752?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925008752?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T14:04:33Z","timestamp":1769868273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925008752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":55,"alternative-id":["S0168365925008752"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114263","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a dissolving microneedle patch for transdermal delivery of SARS-CoV-2 mRNA vaccine with enhanced stability and immunogenicity","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114263","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114263"}}